MaxCyte, Inc.

MXCT ·Healthcare, Diagnostics & Research, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $286.7M

Liabilities Breakdown FY2022

Total Liabilities: $32.7M